EENCBE: Evaluation of Ipsilateral Tubal Patency After Conservative Medical or Surgical Treatment.
Study Details
Study Description
Brief Summary
Ectopic Pregnancy is an entity in which a fertilized ovum is implanted outside its normal place, is considered a public health problem worldwide and is one of the main causes of maternal mortality in the first trimester. The availability of high sensitivity methods of detection of gonadotrophins and the use of high resolution transvaginal ultrasonography have allowed an earlier diagnosis of the same, enabling less aggressive treatments such as the use of parenteral MTX, with the intention of avoiding mutilating surgical treatment , preserving the tube and eventually improving future fertility expectations. The surgical treatment is of choice, this can be laparoscopically or by laparotomy. In this case, we need to preserve fertility, the most indicated is linear salpingostomy; In spite of the existence other techniques.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
The EP constitutes a frequent obstetric emergency in Angola and the province of Benguela is not exempt from this health problem. Every day we see women with this pathology, to which, most of them, they undergo a mutilating surgical treatment (salpingectomy) that impedes their future reproductive capacity. The procreation in the African continent and especially in Angola, has great social and family implications that can reach the breaking of marriages and family (broadcast and study of the Public Television of Angola in the program "Na lente" no year 2018 Taking into account the importance of procreation in the welfare and stability of the marital relationship.Main Objectiv: To demonstrate the non-inferiority of conservative treatment with MTX in ipsilateral tubal patency after an uncomplicated ectopic pregnancy compared with surgical treatment with linear salpingostomy in the Hospital General, Angola
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: Medical treatment By administering a single intramuscular dose of 50mg / m2 / Sc of Methotrexate. |
Drug: Medical treatment
The surgical treatment group can be laparoscopically or by laparotomy, using the Linear Salpingostomy technique. Follow-up with β fraction of chorionic gonadotropin on days 0, 3, 7 and 14 together with gynecological abdominal or transvaginal ultrasound on day 0 and 7 and hysterosalpingography will be performed after three months of treatment.
Other Names:
|
| Active Comparator: Surgical treatment Will be performed by laparoscopy or laparotomy, using the Linear Salpingostomy technique. |
Drug: Medical treatment
The surgical treatment group can be laparoscopically or by laparotomy, using the Linear Salpingostomy technique. Follow-up with β fraction of chorionic gonadotropin on days 0, 3, 7 and 14 together with gynecological abdominal or transvaginal ultrasound on day 0 and 7 and hysterosalpingography will be performed after three months of treatment.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Incidence of Ipsilateral tubal patency [A hysterosalpingography will be performed 3 months after the treatment.]
Incidence of Ipsilateral tubal patency
Secondary Outcome Measures
- Incidence of Achieve the gestation and the culmination. [Up to two years]
Incidence of Achieve the gestation and the culmination.
Eligibility Criteria
Criteria
Inclusion Criteria:
Patient presenting with Ectopic Pregnancy, associated with quantitative titers of βHCG ≥ 100 mUI / ml, without intrauterine gestational sac.
Patient presenting uncomplicated Ectopic Pregnancy with an adnexal mass diameter ≤4 cm diagnosed by abdominal and / or transvaginal ultrasonography.
Absence of heartbeat. No toxicity to MTX. Normal laboratory tests (blood count, coagulogram, liver and kidney function). Hemodynamic stability.
Exclusion Criteria:
-
Complicated Ectopic Pregnancy.
-
Ectopic pregnancy is out of the tuba on ultrasound
-
Patients with Immunosuppression.
-
Allergy to MTX.
-
Patients with Active Respiratory Disease, Blood Dyspasia, Peptic Ulcer, Renal Insufficiency and Hepatic Insufficiency.
-
Do not accept to participate in the study.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Maria Dolores Reguera Saborido | Benguela | Angola | 999 |
Sponsors and Collaborators
- EDGREM Investimentos
- University of Alabama at Birmingham
Investigators
- Study Chair: Moreno Araujo, EDGREN INVESTIMENTOS
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- EDINV-EENC